Lukas Delasos

898 total citations
20 papers, 230 citations indexed

About

Lukas Delasos is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lukas Delasos has authored 20 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lukas Delasos's work include Lung Cancer Treatments and Mutations (8 papers), Radiomics and Machine Learning in Medical Imaging (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Lukas Delasos is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Radiomics and Machine Learning in Medical Imaging (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Lukas Delasos collaborates with scholars based in United States, India and Canada. Lukas Delasos's co-authors include Marc Ladanyi, Romel Somwar, Natasha Rekhtman, Alexander Drilon, Mark G. Kris, James J. Vredenburgh, Andrew J. Plodkowski, Roger S. Smith, Aakash Desai and Kaitlin M. Woo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Lukas Delasos

16 papers receiving 224 citations

Peers

Countries citing papers authored by Lukas Delasos

Since Specialization

Citations

This map shows the geographic impact of Lukas Delasos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Delasos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Delasos more than expected).

Fields of papers citing papers by Lukas Delasos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Delasos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Delasos. The network helps show where Lukas Delasos may publish in the future.

Co-authorship network of co-authors of Lukas Delasos

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas Delasos. A scholar is included among the top collaborators of Lukas Delasos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas Delasos. Lukas Delasos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Computationally integrating radiology and pathology image features for predicting treatment benefit and outcome in lung cancer 2025 ·npj Precision Oncology ·Pranjal Vaidya, Mohammadhadi Khorrami, Kaustav Bera, Pingfu Fu, Lukas Delasos, Amit Gupta, Cristian Barrera, Nathan A. Pennell, Vamsidhar Velcheti, Anant Madabhushi	2
2	Long-term outcomes of Extensive-Stage small cell lung cancer treated with chemotherapy or Chemo-immunotherapy: A propensity score adjusted cohort study 2025 ·Lung Cancer ·(unknown), Emily C. Zabor, (unknown), Monica Lee, (unknown), Meera Patel, Hadil Zureigat, Ahmed Mohamed, (unknown), (unknown), (unknown), Lukas Delasos, Khaled A. Hassan, Nathan A. Pennell, (unknown), James Stevenson, Alex A. Adjei, Moaath K. Mustafa Ali	0
3	Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLC 2024 ·npj Precision Oncology ·Lukas Delasos, Mohammadhadi Khorrami, Vidya Sankar Viswanathan, Khalid Jazieh, Yifu Ding, (unknown), Kevin L. Stephans, Amit Gupta, Nathan A. Pennell, Pradnya D. Patil, Kristin Higgins, Anant Madabhushi	5
4	1222P Predicting pathological complete response to neoadjuvant chemoimmunotherapy in resected NSCLC with radiomic signatures 2024 ·Annals of Oncology ·Mohammadhadi Khorrami, (unknown), Lukas Delasos, (unknown), Nathan A. Pennell, Anant Madabhushi	0
5	Clinical Outcomes With Pembrolizumab-Based Therapies in Recurrent/Refractory NSCLC After Chemoradiation and Consolidative Durvalumab 2023 ·Clinical Lung Cancer ·Lukas Delasos, Wei Wei, Khaled A. Hassan, Nathan A. Pennell, Pradnya D. Patil, James Stevenson	7
6	Texture-based CT radiomics distinguishes radiation and immunotherapy induced pneumonitis in stage III NSCLC. 2022 ·Journal of Clinical Oncology ·Lukas Delasos, Vidya Sankar Viswanathan, Mohammadhadi Khorrami, Khalid Jazieh, Nathan A. Pennell, Anant Madabhushi, Pradnya D. Patil	0
7	The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions 2021 ·Clinical Cancer Research ·Igor Odintsov, (unknown), (unknown), (unknown), Zebing Liu, Lukas Delasos, (unknown), (unknown), Morana Vojnic, Inna Khodos, Marissa S. Mattar, Elisa de Stanchina, (unknown), Marc Ladanyi, Romel Somwar	31
8	Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers 2021 ·Journal of Thoracic Oncology ·Igor Odintsov, Marissa S. Mattar, (unknown), Michael Offin, (unknown), Lukas Delasos, Inna Khodos, Marina Asher, (unknown), Natasha Rekhtman, Elisa de Stanchina, Gopinath Ganji, Marc Ladanyi, Romel Somwar	21
9	Abstract P233: TAS0953/HM06 is effective in preclinical models of diverse tumor types driven by RET alterations 2021 ·Molecular Cancer Therapeutics ·Igor Odintsov, (unknown), Kota Ishizawa, Lukas Delasos, (unknown), Inna Khodos, (unknown), Qing Chang, Marissa S. Mattar, Morana Vojnic, Siddharth Kunte, Annalisa Bonifacio, Claudio Giuliano, Elisa de Stanchina, Emily H. Cheng, Emanuela Lovati, Marc Ladanyi, Romel Somwar	5
10	Membrane‐based therapeutic plasma exchange: Hemodynamics and operational characteristics leading to procedure failure 2021 ·Journal of Clinical Apheresis ·(unknown), Lukas Delasos, (unknown), (unknown), Jinjian Mu, André A. Kaplan	2
11	Primary central nervous system diffuse large B‐cell lymphoma masqueraded as Bing‐Neel syndrome: Steps in management and review of future directions 2021 ·SHILAP Revista de lepidopterología ·Lukas Delasos, (unknown), (unknown), (unknown), James J. Vredenburgh	1
12	Primary central nervous system marginal zone B‐cell lymphoma arising from the dural meninges: A case report and review of literature 2020 ·SHILAP Revista de lepidopterología ·(unknown), Lukas Delasos, Syed Daniyal Asad, Manish Kumar, Jonathan S. Harrison	8
13	Differences in rates of low-dose computed tomography screening for lung cancer amongst various outpatient care centers. 2020 ·Journal of Clinical Oncology ·Lukas Delasos, (unknown), (unknown), (unknown), (unknown), (unknown)	0
14	Primary Bone Lymphoma: A Case Series and Review of Literature 2020 ·SHILAP Revista de lepidopterología ·Poorva Bindal, Aakash Desai, Lukas Delasos, (unknown), James J. Vredenburgh	17
15	New onset diabetes with ketoacidosis following nivolumab immunotherapy: A case report and review of literature 2020 ·Journal of Oncology Pharmacy Practice ·Lukas Delasos, Christopher G. Bazewicz, (unknown), (unknown), James J. Vredenburgh	12
16	P1.14-50 A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma 2019 ·Journal of Thoracic Oncology ·Robin Guo, Isabel R. Preeshagul, Adam J. Schoenfeld, Caroline G. McCarthy, Alex Makhnin, Andrew J. Plodkowski, Michelle S. Ginsberg, Monika A. Davare, Lukas Delasos, Romel Somwar, Maria E. Arcila, Gregory J. Riely, Natasha Rekhtman, Marc Ladanyi, Mark G. Kris, Alexander Drilon	3
17	MET inhibitor resistance in patients with MET exon 14-altered lung cancers. 2019 ·Journal of Clinical Oncology ·Robin Guo, Michael Offin, A. Rose Brannon, Andrew Chow, Lukas Delasos, Romel Somwar, Olivia Wilkins, (unknown), Yuan Tian, Franco Cecchi, Todd Hembrough, Bob T. Li, Charles M. Rudin, Mark G. Kris, Maria E. Arcila, Natasha Rekhtman, Paul K. Paik, Marc Ladanyi, Ahmet Zehir, Alexander Drilon	22
18	A Case of Immunotherapy-Induced Colitis Complicated by Perforation and Treated with Infliximab Postoperatively 2019 ·SHILAP Revista de lepidopterología ·Lukas Delasos, Aakash Desai, (unknown), (unknown), Carolyn M. Ray	6
19	OA11.05 A Phase 2 Study of Cabozantinib for Patients with Advanced RET-Rearranged Lung Cancers 2017 ·Journal of Thoracic Oncology ·Alexander Drilon, Romel Somwar, Roger S. Smith, Lukas Delasos, Melanie Albano, (unknown), Lu Wang, Natasha Rekhtman, Ai Ni, Andrew J. Plodkowski, Michelle S. Ginsberg, Gregory J. Riely, Charles M. Rudin, Marc Ladanyi, Mark G. Kris	1
20	Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers 2016 ·Annals of Oncology ·Alexander Drilon, Isabella Bergagnini, Lukas Delasos, Joshua K. Sabari, Kaitlin M. Woo, Andrew J. Plodkowski, (unknown), Matthew D. Hellmann, Philippe Joubert, Cami S. Sima, Roger S. Smith, Romel Somwar, Natasha Rekhtman, Marc Ladanyi, (unknown), Mark G. Kris	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact